Concepedia

Publication | Closed Access

Fatigue therapy in multiple sclerosis

DOI

356

Citations

0

References

1995

Year

Lauren Krupp, Patricia K. Coyle, C. Doscher, A. Miller, Anne H. Cross, Lina Jandorf, James Halper, Brian P. Johnson, L. Morgante, Roger Grimson
Neurology

Abstract

Amantadine was significantly better than placebo in treating fatigue in MS patients, whereas pemoline was not. The benefit of amantadine was not due to changes in sleep, depression, or neurologic disability.